Sonoma Pharmaceuticals Ratios (2010-2012) | SNOA

Ratios Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012
Profitability
Gross Margin 61.35%67.84%49.68%71.19%66.29%75.84%66.38%63.71%71.19%70.70%69.80%
EBT Margin -108.44%-70.24%-94.47%-56.66%-74.12%-23.45%-93.66%-52.04%-19.30%-24.22%-26.95%
EBIT Margin -105.83%-66.71%-89.84%-51.13%-68.64%-17.20%-84.37%-43.72%-12.22%-18.05%-19.21%
EBITDA Margin -109.41%-61.80%-97.28%-59.39%-72.86%-27.65%-94.41%-49.51%8.02%-30.93%-54.46%
Operating Margin -105.83%-66.71%-89.84%-51.13%-68.64%-17.20%-84.37%-43.72%-12.22%-18.05%-19.21%
Net Margin -108.44%-70.24%-94.47%-56.66%-73.98%-23.45%-91.29%-52.04%-15.23%-24.22%-54.01%
FCF Margin -66.78%-51.62%-71.03%-6.46%-20.10%-26.73%-43.94%-46.91%-31.25%99.34%-32.88%
Efficiency
Inventory Average 0.75M0.82M0.95M0.98M0.89M0.85M0.89M
Assets Average 9.84M8.86M8.54M8.94M8.49M8.37M8.41M8.77M11.54M12.61M
Equity Average 1.04M0.13M0.01M-0.35M-0.26M-0.08M1.31M
Invested Capital 2.61M1.19M0.72M1.11M0.55M1.82M1.05M6.16M
Asset Utilization Ratio 1.141.171.371.451.521.581.281.23
Leverage & Solvency
Interest Coverage Ratio -40.61-18.69-19.06-9.24-12.46-2.74-9.05-5.25-1.72-2.92-2.47
Debt to Equity 1.507.52-18.7719.84-3.738.55-5.280.50
Debt Ratio 0.290.320.330.360.410.300.200.13
Equity Ratio 0.200.04-0.020.02-0.110.04-0.040.26
Times Interest Earned -40.61-18.69-19.06-9.24-12.46-2.74-9.05-5.25-1.72-2.92-2.47
Valuation
Enterprise Value 46.86M35.63M39.98M44.20M44.08M36.84M23.29M35.02M19.63M22.29M16.03M
Market Capitalization 53.53M40.99M44.65M48.57M49.10M40.46M28.25M38.38M24.03M30.60M22.62M
Return Ratios
Return on Sales -0.81%-0.73%-0.58%-0.59%-0.58%-0.43%-0.42%-0.30%
Return on Capital Employed -1.82%-1.75%-1.43%-1.60%-1.77%-1.66%-1.25%-0.47%
Return on Assets -0.93%-0.85%-0.80%-0.86%-0.88%-0.68%-0.54%-0.36%
Return on Equity -7.31%-53.86%-532.37%20.98%22.81%78.43%-3.48%